Table 2.
Indicators of acceptability and coverage of MDA and IRS
| Indicator | Time point, % (95% CL) | |||
|---|---|---|---|---|
| Baseline (T0) | Survey 1 (T1) | Survey 2 (T2) | Survey 3 (T3) | |
| HH willing to take medications for malaria elimination campaign, head of HH response | 99.2 (98.2–100) | – | – | – |
| Individuals who took MDA medications | – | 89.6 (87.3–92.0) | 86.9 (83.4–90.4) | 74.9 (69.9–79.2) |
| Individuals who would take MDA again among those who took medications during campaign | – | 99.6 (99.2–100) | – | – |
| HH willing to accept IRS for malaria elimination campaign | 99.9 (99.8–100) | – | – | – |
| HH was sprayed (no OU 14) | – | 48.9 (41.5–56.3) | 60.6 (53.0–68.1) | 52.6 (45.3–59.9) |
| HH that would accept IRS again among those that had IRS during campaign | – | 85.0 (80.3–89.7) | – | – |
| HH owns any bed net | 3.2 (0–9.8), OU 14 only | 11.4 (0.3–22.5), OU 14 only | 97.2 (91.6–100), OU 14 only; 44.8 (38.9–50.7), all OUs | 34.4 (17.0–51.8), OU 14 only; 33.5 (27.9–39.1), all OUs |
| HH with at least one member who participated in MDA and received IRS | – | 42.6 (34.2–51.0) | 57.3 (49.2–65.3) | 44.1 (36.4–51.7) |
| HH with at least one member who participated in MDA and owns any LLINs (OU 14 only) | – | – | 97.2 (91.6–100) | – |
CL = confidence limit; HH = household; IRS = indoor residual spraying; LLINs: long-lasting insecticide-treated nets; MDA = mass drug administration; OU = operational unit; T0 = baseline survey; T1 = 10 weeks; T2 = 6 months; T3 = 14 months.